BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33155366)

  • 1. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
    Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
    Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitylation and stabilization of PTEN by USP13.
    Zhang J; Zhang P; Wei Y; Piao HL; Wang W; Maddika S; Wang M; Chen D; Sun Y; Hung MC; Chen J; Ma L
    Nat Cell Biol; 2013 Dec; 15(12):1486-1494. PubMed ID: 24270891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
    Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
    PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.
    Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T
    Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression.
    Guo Y; He J; Zhang H; Chen R; Li L; Liu X; Huang C; Qiang Z; Zhou Z; Wang Y; Huang J; Zhao X; Zheng J; Chen GQ; Yu J
    Oncogene; 2022 Oct; 41(44):4877-4892. PubMed ID: 36192478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
    Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
    Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
    Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
    Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
    [No Abstract]   [Full Text] [Related]  

  • 12. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.
    Jia X; Chen H; Ren Y; Dejizhuoga ; Gesangyuzhen ; Gao N; Feng H; Huang W; Liao Y; Yu H
    Exp Cell Res; 2021 May; 402(1):112506. PubMed ID: 33516665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
    Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
    Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
    Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
    Nacerddine K; Beaudry JB; Ginjala V; Westerman B; Mattiroli F; Song JY; van der Poel H; Ponz OB; Pritchard C; Cornelissen-Steijger P; Zevenhoven J; Tanger E; Sixma TK; Ganesan S; van Lohuizen M
    J Clin Invest; 2012 May; 122(5):1920-32. PubMed ID: 22505453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
    Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
    Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 regulates AMPK-mTOR signalling pathway through deubiquitinating and stabilizing tumour-suppressor LKB1.
    Yang C; Ding H; Yang Y; Yang L; Yang Y; Fang M; Ren J; Hu R; Wang C; Geng W
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1025-1032. PubMed ID: 32819560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
    Christine A; Park MK; Song SJ; Song MS
    Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
    Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
    J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.